Dr. John Burd is the founder and CEO of Lysulin, Inc and Wonder Spray, LLC.
He founded Lysulin, Inc, developing scientifically proven nutraceutical products to improve the health of people with diabetes. The first patented product, Lysulin®, was launched in January 2018 and it's showing remarkable results in clinical studies in lowering HbA1c and glycated proteins, the cause of disease complications.
Dr. Burd was previously President & CEO of DexCom, where he directed the company’s work to develop, manufacture and market the first long-term implantable glucose sensor for people with diabetes. He has authored and co-authored over 45 articles and his work in the medical and biotechnology field has led to the filing and ownership of 40 patents and the development of many innovative medical products. He graduated from Purdue University with a B.S. in Biochemistry, and earned an M.S. and Ph.D., also in Biochemistry, from the University of Wisconsin.
Discussed in this episode:
Links of interest and Dr. Burd's contact information: